Search
for
Sort by
Research 421–450 of 784
- Comparative study between fractional CO2 laser alone versus fractional CO2 laser combined with topical dutasteride in treatment of male androgenic alopecia
- Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice
- 5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update
- Acupuncture for treating alopecia areata: A systematic review and meta-analysis
- An overview on 5α-reductase inhibitors
- Synthesis and 5α-Reductase Inhibitory Activity of C21 Steroids Having 1,4-diene or 4,6-diene 20-ones and 4-Azasteroid 20-Oximes
- Localization, Age- and Site-Dependent Expression, and Regulation of 11β-Hydroxysteroid Dehydrogenase Type 1 in Skin
- Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor
- Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
- Investigation on the Mechanism of <i>Platycladus</i> <i>orientalis</i> in the Treatment of Androgenetic Alopecia Based on Machine Learning and Molecular Dynamics
- Nanotechnology-based topical treatments for androgenic alopecia
- Highlights from JAAD Reviews: August 2025—Bicalutamide for female hair loss
- Long-term use of dutasteride to treat androgenic alopecia in young men may lead to persistent abnormalities in semen parameters
- Loss of epidermal PLCg1 induced sebaceous gland hyperplasia and sparse hair
- Synthesis of avicequinone c and analogs toward the study of 5α-reductase inhibitory activity
- A method for simultaneous analysis of androgens, dutasteride and finasteride in human serum by liquid chromatography tandem mass spectrometry
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
- Polymorphism of the Androgen Receptor Gene is Associated with Male Pattern Baldness
- Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin
- Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study
- 13C-NMR study of 4-azasteroids in solution and solid state
- Minoxidil may suppress androgen receptor-related functions
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells
- Development of a new gas chromatography–mass spectrometry (GC–MS) methodology for the evaluation of 5α-reductase activity
- Invalidation of a commercially available human 5α-dihydrotestosterone immunoassay
- Establishment of type II 5α-reductase over-expressing cell line as an inhibitor screening model
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- Transcriptomic characterization of Lonrf1 at the single-cell level under pathophysiological conditions